These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28583663)

  • 21. Cervical cancer prevention: new guidelines in the United States and new opportunities for low- and middle-income countries.
    Waxman AG
    Obstet Gynecol Clin North Am; 2013 Jun; 40(2):251-5. PubMed ID: 23732029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system.
    Chao C; Silverberg MJ; Becerra TA; Corley DA; Jensen CD; Chen Q; Quinn VP
    Am J Obstet Gynecol; 2017 Feb; 216(2):151.e1-151.e9. PubMed ID: 27746152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus (HPV) vaccination and the development of public policies.
    Lippman A
    J Epidemiol Community Health; 2008 Jul; 62(7):570-1. PubMed ID: 18559435
    [No Abstract]   [Full Text] [Related]  

  • 24. Whatever happened to the annual pap smear?
    Vigliani MB
    R I Med J (2013); 2013 Jan; 96(1):36-8. PubMed ID: 23638458
    [No Abstract]   [Full Text] [Related]  

  • 25. Beyond the Statistics: What HPV Means to Women's Lives.
    Perkins RB; Felder T
    Acad Pediatr; 2018 Mar; 18(2S):S21-S22. PubMed ID: 29502632
    [No Abstract]   [Full Text] [Related]  

  • 26. Introducing HPV vaccine in developing countries--key challenges and issues.
    Agosti JM; Goldie SJ
    N Engl J Med; 2007 May; 356(19):1908-10. PubMed ID: 17494923
    [No Abstract]   [Full Text] [Related]  

  • 27. HPV vaccination: effects on cervical screening.
    Kothari A
    Nurs Times; 2014 Jun 11-17; 110(24):19-21. PubMed ID: 25007499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus vaccines: new tools for accelerating cervical cancer prevention in developing countries.
    Luciani S; Jauregui B; Kieny C; Andrus JK
    Immunotherapy; 2009 Sep; 1(5):795-807. PubMed ID: 20636024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cervical cancer: what is the optimal age for routine testing?
    Rob L; Tachezy R; Robova H
    Future Oncol; 2015; 11(8):1137-40. PubMed ID: 25832869
    [No Abstract]   [Full Text] [Related]  

  • 30. [AN HPV-ASSOCIATED DISEASES AND CERVICAL CANCER AND PROPHYLACTIC HUMAN PAPILLOMAVIRUS (HPV) VACCINES].
    Malinova M
    Akush Ginekol (Sofiia); 2015; 54 Suppl 1():25-31. PubMed ID: 26137767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early effects of human papillomavirus vaccination in Belgium.
    Merckx M; Vanden Broeck D; Benoy I; Depuydt C; Weyers S; Arbyn M
    Eur J Cancer Prev; 2015 Jul; 24(4):340-2. PubMed ID: 25117724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Human papillomavirus infection. Screening, treatment and vaccination].
    Aubin F
    Rev Prat; 2006 Nov; 56(17):1875-6. PubMed ID: 17243383
    [No Abstract]   [Full Text] [Related]  

  • 33. Reducing the burden of cervical cancer and HPV-related diseases through vaccination. Introduction.
    Cox JT
    Curr Opin Obstet Gynecol; 2006 Feb; 18 Suppl 1():s3-4. PubMed ID: 16520682
    [No Abstract]   [Full Text] [Related]  

  • 34. Human papillomavirus screening for low and middle-income countries.
    Suba EJ; Zarka MA; Raab SS
    Prev Med; 2017 Jul; 100():296. PubMed ID: 28583662
    [No Abstract]   [Full Text] [Related]  

  • 35. Human papillomavirus-related content in state and tribal comprehensive cancer control plans.
    Steele CB; Thomas CN; Richardson LC
    J Womens Health (Larchmt); 2008; 17(1):5-10. PubMed ID: 18240976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cancer of cervix in Chile. Too much vaccine amid a neglected Papanicolau].
    Fica A
    Rev Chilena Infectol; 2014 Apr; 31(2):196-203. PubMed ID: 24878908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New vaccines and screening can reduce cervical cancer incidence in poor countries.
    Watson R
    BMJ; 2008 Sep; 337():a1545. PubMed ID: 18768548
    [No Abstract]   [Full Text] [Related]  

  • 38. Human papillomavirus vaccine.
    Suba EJ; Raab SS;
    N Engl J Med; 2007 Sep; 357(11):1155; author reply 1155-6. PubMed ID: 17874469
    [No Abstract]   [Full Text] [Related]  

  • 39. Cervical cancer control in Latin America: A call to action.
    Bychkovsky BL; Ferreyra ME; Strasser-Weippl K; Herold CI; de Lima Lopes G; Dizon DS; Schmeler KM; Del Carmen M; Randall TC; Nogueira-Rodrigues A; de Carvalho Calabrich AF; St Louis J; Vail CM; Goss PE
    Cancer; 2016 Feb; 122(4):502-14. PubMed ID: 26670695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Vaccination perspective against human papillomavirus and consequences for the screening of uterine cervical neoplasm].
    Delvenne P
    Bull Mem Acad R Med Belg; 2007; 162(10-12):483-8; discussion 489-90. PubMed ID: 18557390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.